Beijing Yaguo Technology Co., Ltd.
4 Articles found

Beijing Yaguo Technology Co., Ltd. articles

Research paper related to ResPower Respiratory Neuromuscular Stimulator was accepted by ERS International Congress

Respiratory Neuromuscular Stimulator was used in clinical research in Beijing Chaoyang Hospital affiliated to Capital Medical University, the First Hospital of Hebei Medical University and Tianjin Chest Hospital. Subsequently, the articles were submitted one after another and were accepted by

Jul. 2, 2022

Objective
To investigate the rehabilitation value of respiratory neuromuscular Electrical Stimulation. In Pulmonary Rehabilitation of COPD patients.
Method
126 patients (85 males and 41 females) with stable Grade-D CODP to GOLD2017 guideline were involved in the RCT study. All cases were divided into stimulation group(n=63) and Control Group(n=63). All patients wer
Jul. 2, 2022

At the beginning of Chinese New Year, Beijing Yaguo Technology Co., Ltd.`s innovative medical device "Respiratory Power" respiratory neuromuscular stimulator was officially launched. "Respiratory power" has been established in 2015 as a core innovative product of Yaguo, Through 4 years of continuously efforts, after research, demonstration, design, development, and clinical registration it has been awarded in Beijing as a respiratory therapy device. The medical device registration certificate

Jan. 4, 2020

Clinical analysis of 25 novel coronavirus pneumonia deaths:asphyxia due to pulmonary mucus Pengpai news reporter Wu Yi Pengpai news ,February 29

On February 25, MedRxiv published a paper from Wuhan University People`s

Hospital, Clinical characteristics of 25 death cases infected with COVID-19 pneumonia: a retrospective review of medical records in a single medical center, Wuhan, China. The corresponding author is Gong zuojong, director of the Department of i
Feb. 1, 2020

Contact supplier

Drop file here or browse